On April 2, 2019, the Federal Food and Drug Administration (FDA) issued a statement and announced a public hearing on consumer products derived from cannabis and its components, including cannabidiol (CBD). Recognizing the need to provide clarity on the authority of FDA to regulate these products, and what pathways are available for marketing them, the
Rickie Sonpal has a broad-based corporate and transactional practice that encompasses mergers and acquisitions, partnerships and joint ventures, debt and equity financing, and general corporate and commercial matters. He is a member of the firm's Business Transactions and Finance Groups. He is also a member of the firm's Business Transactions Group.